BG Medicine To Transfer To The NASDAQ Capital Market; Obtains Requested NASDAQ Extension

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WALTHAM, Mass., Jan. 27, 2014 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) (the "Company") announced today that the NASDAQ Listing Qualifications Panel (the "Panel") has granted the Company's request for the transfer of its listing from The NASDAQ Global Market to The NASDAQ Capital Market, which transfer will be effective with the open of business today. The Company's securities will continue to trade on NASDAQ under the symbol "BGMD."

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC